Results 201 to 210 of about 9,643,208 (350)

Neuroprotection in Parkinson Disease. [PDF]

Neurol Ther
Gonzalez-Robles C, Bandmann O, Schapira AHV.   +2 more
europepmc   +1 more source

EXERCISES WITH AND WITHOUT VIRTUAL REALITY ON PAIN IN PATIENTS WITH PARKINSON DISEASE: A RANDOMIZED, CONTROLLED, SINGLE-BLIND TRIAL

, 2017
Matheus Silva d’Alencar, Jean Alex Matos Ribeiro, Rafael Viní­cius Santos Cruz, Kátia Nunes Sá, Elen Beatriz Pinto, Abrahão Fontes Baptista   +5 more
openalex   +1 more source

Chronic systemic pesticide exposure reproduces features of Parkinson's disease

Nature Neuroscience, 2000
R. Betarbet, T. Sherer, G. Mackenzie, M. Garcia-Osuna, A. Panov, J. Greenamyre   +5 more
semanticscholar   +1 more source

Inhibition of SLC11A1‐Mediated Lysosomal Iron Accumulation in Microglia Promotes Repair Following White Matter Stroke

Advanced Science, EarlyView.
Genetic and pharmacological inhibition of SLC11A1 functioning as an H+/Fe2+ antiporter–mediated lysosomal iron accumulation in microglia promotes lysosomal lumen acidification, increases CTSD expression, enhances lysosomal myelin debris uptake and degradation, and promotes repair following white matter stroke. ABSTRACT White matter stroke (WMS) results
Lingling Qiu, Yajie Zhang, Yushi Tang, Hongli Hu, Ying Zhang, Junwen Xue, Hao Wang, Yecheng Wang, Chunfeng Liu, Jia Jia, Jian Cheng, Yongjun Cao   +11 more
wiley   +1 more source

Olfactory Dysfunction as a Window Into the Heterogeneity of Parkinson Disease. [PDF]

Eur J Neurol
Sun Y, Na HK, Yoon SH, Vo QP, Park CW, Lee JH, Choi YY, Yoo HS, Sohn YH, Lyoo CH, Lee PH.   +10 more
europepmc   +1 more source

Serum albumin, cognitive function, motor impairment, and survival prognosis in Parkinson disease

, 2022
Shujun Sun, Yiyong Wen, Yandeng Li
openalex   +1 more source

Parabiosis, Assembloids, Organoids (PAO)

Advanced Science, EarlyView.
This review evaluates parabiosis, organoids, and assembloids as complementary disease models spanning systemic, organ, and multi‐organ levels. It highlights their construction strategies, applications, and current limitations, while emphasizing their integration with frontier technologies such as artificial intelligence, organ‐on‐a‐chip, CRISPR, and ...
Yang Hong, Lavonda Li, Lijie Yan, Long Bai, Jiacan Su, Xingcai Zhang   +5 more
wiley   +1 more source

Association of TRPV1 genetic variants with cognitive functions in Parkinson disease. [PDF]

iScience
Yao WS, Yu RL, Tan CH.
europepmc   +1 more source

Microglial HVCN1 Deficiency Improves Movement and Survival of SOD1G93A ALS Mice by Enhancing Microglial Migration and Neuroprotection

Advanced Science, EarlyView.
Hydrogen voltage gated channel 1 (HVCN1) is upregulated in microglia of both ALS patients and its mouse model. HVCN1 deficiency enhances microglial migration via suppressing Akt signaling, promotes neurotrophic capacity and motor function, and prolongs survival of the SOD1G93A ALS mice. This study identifies HVCN1 as a novel, promising druggable target
Fan Wang, Ke‐Yu Zhang, Lang‐Jian Zhu, Wei‐Jue Li, Yang Wu, Xiang Gao, Xiao‐Ru Ma, Xiu‐Hua Yin, Jian‐Bin Wu, Xiao‐Kang Ye, Zhao‐Jun Dong, Di‐Xian Wang, Zhe Zhou, Shao‐Dong Wang, Lei Han, Zhi‐Nong Jiang, Jing‐Wei Zhao   +16 more
wiley   +1 more source

A Unique Case of Metastatic Paraganglioma in a Patient With Parkinson Disease. [PDF]

JCEM Case Rep
Aye ST, Oo TD, Lwin NA.
europepmc   +1 more source